Many tumors exhibit elevated chromosome mis-segregation termed chromosome instability (CIN), which is likely to be a potent driver of tumor progression and drug resistance. Causes of CIN are poorly understood but probably include prior genome tetraploidization, centrosome amplification and mitotic checkpoint defects. This study identifies epigenetic alteration of the centromere as a potential contributor to the CIN phenotype. The centromere controls chromosome segregation and consists of higher-order repeat (HOR) alpha-satellite DNA packaged into two chromatin domains: the kinetochore, harboring the centromere-specific H3 variant centromere protein A (CENP-A), and the pericentromeric heterochromatin, considered important for cohesion. Perturbation of centromeric chromatin in model systems causes CIN. As cancer cells exhibit widespread chromatin changes, we hypothesized that pericentromeric chromatin structure could also be affected, contributing to CIN. Cytological and chromatin immunoprecipitation and PCR (ChIP-PCR)-based analyses of HT1080 cancer cells showed that only one of the two HORs on chromosomes 5 and 7 incorporate CENP-A, an organization conserved in all normal and cancer-derived cells examined. Contrastingly, the heterochromatin marker H3K9me3 (trimethylation of H3 lysine 9) mapped to all four HORs and ChIP-PCR showed an altered pattern of H3K9me3 in cancer cell lines and breast tumors, consistent with a reduction on the kinetochore-forming HORs. The JMJD2B demethylase is overexpressed in breast tumors with a CIN phenotype, and overexpression of exogenous JMJD2B in cultured breast epithelial cells caused loss of centromere-associated H3K9me3 and increased CIN. These findings suggest that impaired maintenance of pericentromeric heterochromatin may contribute to CIN in cancer and be a novel therapeutic target.
Many tumors exhibit elevated chromosome mis-segregation termed chromosome instability (CIN), which is likely to be a potent driver of tumor progression and drug resistance. Causes of CIN are poorly understood but probably include prior genome tetraploidization, centrosome amplification and mitotic checkpoint defects. This study identifies epigenetic alteration of the centromere as a potential contributor to the CIN phenotype. The centromere controls chromosome segregation and consists of higher-order repeat (HOR) alpha-satellite DNA packaged into two chromatin domains: the kinetochore, harboring the centromere-specific H3 variant centromere protein A (CENP-A), and the pericentromeric heterochromatin, considered important for cohesion. Perturbation of centromeric chromatin in model systems causes CIN. As cancer cells exhibit widespread chromatin changes, we hypothesized that pericentromeric chromatin structure could also be affected, contributing to CIN. Cytological and chromatin immunoprecipitation and PCR (ChIP-PCR)-based analyses of HT1080 cancer cells showed that only one of the two HORs on chromosomes 5 and 7 incorporate CENP-A, an organization conserved in all normal and cancer-derived cells examined. Contrastingly, the heterochromatin marker H3K9me3 (trimethylation of H3 lysine 9) mapped to all four HORs and ChIP-PCR showed an altered pattern of H3K9me3 in cancer cell lines and breast tumors, consistent with a reduction on the kinetochore-forming HORs. The JMJD2B demethylase is overexpressed in breast tumors with a CIN phenotype, and overexpression of exogenous JMJD2B in cultured breast epithelial cells caused loss of centromere-associated H3K9me3 and increased CIN. These findings suggest that impaired maintenance of pericentromeric heterochromatin may contribute to CIN in cancer and be a novel therapeutic target.
Introduction
Cancer cells accumulate somatic mutations and other genomic rearrangements, which impair the normal mechanisms controlling cell proliferation and differentiation, culminating in malignancy. One mechanism to accelerate the loss or gain of tumor suppressor genes and oncogenes, which often accompanies tumorigenesis, is chromosome mis-segregation resulting in the gain or loss of entire chromosomes (aneuploidy). The majority of solid tumors exhibit numerical chromosomal abnormality (Mitelman et al., 1994) . Although clonal selection of rare aneuploid cells arising from basal mis-segregation rates may partly account for tumor aneuploidy (Cahill et al., 1999) , many tumors are thought to acquire an elevated mis-segregation rate referred to as chromosomal instability (CIN), which has been proposed as a potent driver of tumor progression and drug resistance (Kops et al., 2005) . Likely causes of CIN include multipolar mitoses following genome tetraploidization and centrosome amplification, chromatid cohesion defects and impairment of the mitotic checkpoint pathways that ensure faithful chromosome segregation (Thompson et al., 2010) . However, the full spectrum of changes underlying the CIN phenotype remains to be uncovered. This study presents new evidence implicating epigenetic impairment of the centromere as a contributing factor.
The centromere is the nucleoprotein complex at the core of the segregation machinery. Its functions include sister chromatid cohesion, attachment to the mitotic spindle and management of the mitotic checkpoint. Centromeres assemble on the megabase-sized blocks of alpha-satellite DNA located at the primary constriction of all human chromosomes. Alpha-satellite DNA comprises tandem 171 bp monomers. Groups of monomers are themselves reiterated, giving rise to a higher-order repeat (HOR) structure, which is unique to each centromere (Warburton and Willard, 1996) . Despite this sequence heterogeneity, the basic chromatin architecture of the centromere is well conserved and critical to its function (Verdaasdonk and Bloom, 2011) . At the microtubule attachment region (kinetochore) the core histone protein H3 is partially substituted by a centromere-specific H3 variant, centromere protein A (CENP-A) (Palmer et al., 1987; Sullivan and Karpen, 2004) . Alpha-satellite DNA flanking the kinetochore assembles the pericentromeric heterochromatin compartment, which folds between sister kinetochores on the metaphase chromosome, and is characterized by abundant methylation of H3 at lysine 9 (H3K9) (Sullivan and Karpen, 2004; Alonso et al., 2010) . CENP-A deposition provides a foundation for the kinetochore Warburton et al., 1997) , whereas methylated H3K9 serves as a docking site for the heterochromatin protein HP1 (Bannister et al., 2001) , and has been implicated in centromeric cohesion at mitosis (Bernard et al., 2001; Guenatri et al., 2004; Alonso et al., 2010) . The function of the centromere is therefore vulnerable to disruption of the pathways that maintain this unique chromatin architecture. CENP-A overexpression is seen in breast and colon cancer and has been linked to a CIN phenotype (Perou et al., 2000; Tomonaga et al., 2003; Amato et al., 2009) , and engineered disruption of pericentromeric heterochromatin is associated with chromosome mis-segregation and tumorigenesis (Ekwall et al., 1997; Bernard et al., 2001; Peters et al., 2001; David et al., 2003; Shin et al., 2003; Gonzalo et al., 2005; David et al., 2006; Bourgo et al., 2009) . Furthermore, targeting of chromatin modifiers to human artificial chromosomes disrupts centromere function (Nakano et al., 2008; Cardinale et al., 2009; Bergmann et al., 2011) .
Epigenetic gene mis-regulation in cancer is well documented, reflecting aberrant patterns of both histone and DNA methylation as well as histone acetylation. Some of the enzymatic pathways involved have been targeted therapeutically (Rodriguez-Paredes and Esteller, 2011) . In contrast, the impact of epigenetic perturbation on centromere function in human cancer remains largely unexplored. The available data support the generic model of centromere structure outlined above, in which HOR alpha-satellite DNA is partitioned into two adjacent chromatin domains. However, autosomal centromeres harbor multiple divergent HOR alpha-satellite blocks (Lee et al., 1997) whose contributions to centromeric chromatin assembly are not well defined. The present study combines molecular and cytological approaches to map the kinetochore and flanking heterochromatin domains to the underlying HOR blocks on chromosomes 5 and 7, revealing a well conserved centromeric organization in normal cells and tissues. In comparison, tumor-derived cells with a CIN phenotype exhibited a profile of epigenetic change at both centromeres, consistent with a loss of kinetochoreproximal trimethylated H3K9 (H3K9me3). H3K9me3 maintenance depends on the opposing activities of the SUV39H1/2 histone methyltransferases, which are required for proper chromosome segregation in mice (Peters et al., 2001) , and the recently discovered JMJD2 family of histone demethylases, which reverse trimethylation on H3K9 and K36 and have been implicated in tumorigenesis (Pedersen and Helin, 2010) . JMJD2 proteins antagonize formation of pericentromeric H3K9me3 in mouse cells (Fodor et al., 2006) , whereas overexpression of JMJD2B or JMJD2C has been reported in a range of cancers including breast cancer (Liu et al., 2009; Pedersen and Helin, 2010; Yang et al., 2010) . Here, we find that overexpression of exogenous JMJD2B in human breast epithelial cells can drive loss of centromere-associated H3K9me3 and increased CIN. The possibility that disruption of pericentromeric heterochromatin promotes CIN and cancer progression, by impairing centromere function, opens new research avenues that may lead to therapeutic interventions targeting the affected pathways.
Results
Mapping the centromere 5 kinetochore in normal and cancer cells A generic scheme of centromere organization showing assembly of CENP-A at the kinetochore and heterochromatin on flanking HOR alpha-satellite is shown in Figure 1a . To investigate how this scheme applies to an individual autosome, we examined the centromere of chromosome 5, which harbors two HORs, D5Z1 and D5Z2 (Finelli et al., 1996) . In silico analysis revealed that only D5Z2 possesses intact CENP-B boxes (Rosandic et al., 2006) (not shown), a 17 bp motif necessary for de novo centromere formation on human artificial chromosomes (Ohzeki et al., 2002) . Consistent with these observations, immunofluorescence (IF) showed that CENP-A colocalized almost exclusively with D5Z2 in chromosome spreads from the HT1080 lung cancer cell line (in 22/27 chromosome 5 examples), suggesting that a portion of D5Z2 forms the kinetochore (Figure 1b) . The remainder of D5Z2 spans the inner centromere region (Figure 1b) . The infrequent overlap of D5Z1 with CENP-A (in 4/27 chromosome 5 examples) is likely to reflect resolution limitations due to chromosome compaction. Chromatin immunoprecipitation and PCR (ChIP-PCR) analysis confirmed that CENP-A is restricted to D5Z2 and excluded from D5Z1 in HT1080 cells (Figure 1b) . HT1080 cells have a near tetraploid karyotype and exhibit chromosome instability upon passage in culture (Grimes et al., 2004) , which could reflect impaired centromere function. To compare the organization of the chromosome 5 centromere in normal cells, the ChIP-PCR analysis was repeated on primary human umbilical vein endothelial cell (HUVEC) preparations from three individuals. Again, CENP-A was restricted to D5Z2 (Supplementary Figure  S1) . A similar CENP-A distribution was observed in both chromosomally unstable HeLa cervical cancer cells and HME5cdk4 normal diploid human breast epithelial cells (Supplementary Figure S1) , suggesting that the site of CENP-A/kinetochore assembly is conserved. The organization of CENP-A, D5Z1 and D5Z2 is summarized in Figure 1b .
FISH analysis showed an absence of detectable D5Z1 sequence on a mitotically stable chromosome 5-derived ring chromosome in a patient sample ( Figure 1c ). The ring 5 chromosome, formed from a deletion within the cen-5p13 region (Schuffenhauer et al., 1996) , retained D5Z2 ( Figure 1c ) and has a kinetochore (Supplementary Figure S2 ). These findings are consistent with D5Z1 representing a chromosome arm sequence outside of the functional centromere.
Altered pericentromeric H3K9me3 distribution on chromosome 5 in cancer cell lines and invasive breast tumors Pericentromeric heterochromatin is considered to be important for sister chromatid cohesion and is characterized by a high density of methylated H3K9, which is absent from the adjacent kinetochore/CENP-A domain (Sullivan and Karpen, 2004) . Using IF in normal HUVECs, H3K9me3 was readily detectable on metaphase chromosomes between the CENP-A/kinetochore signals, and often extended into the surrounding chromatin ( Figure 2a , Supplementary Figure S3 ).
ChIP-PCR with an H3K9me3 antibody showed that both D5Z1 and D5Z2 precipitated with similar efficiency and were enriched 15-and 17-fold relative to the GAPDH reference ( Figure 2a ). To test the possibility that pericentromeric heterochromatin is altered in cancer cells, the dual CENP-A/H3K9me3 IF was repeated in HT1080 cells. In contrast with HUVECs, H3K9me3 was not detectable between the majority of sister kinetochores (Figure 2a , Supplementary Figure   S3 ). This result supports our earlier study, showing that the heterochromatin protein HP1a, which binds to H3K9me3, is often undetectable between the CENP-A signals in HT1080 cells (Grimes et al., 2004) . Consistent with the IF findings, ChIP-PCR with an H3K9me3 antibody showed reduction of H3K9me3 on the D5Z2 kinetochore sequence relative to both the flanking D5Z1 (P ¼ 3 Â 10 À5 ) and GAPDH (P ¼ 0.04) sequences, when HT1080 cells were compared with HUVECs (Figures 2a and b). We next investigated whether the H3K9me3 distribution at the centromere is altered in two additional chromosomally unstable cancer cell lines (HeLa and HCC1937 (a BRCA1 deficient breast cancer cell line)) relative to four normal diploid controls (three HUVEC samples and HME5cdk4 cells) using ChIP-PCR. In comparison to the D5Z1 reference sequence, the tumor-derived cell lines exhibited consistent loss of H3K9me3 from the kinetochore-forming D5Z2 sequence (Pp0.002; Figure 2b ).
The preceding analysis identifies an association between reduced kinetochore proximal heterochromatin and a CIN phenotype in genetically unmatched cell lines. To exclude population variation as the source for epigenetic differences in centromere structure, the ChIP-PCR comparison was repeated in a non-tumorigenic cell line and its tumorigenic derivative. Breast epithelial cells were isolated from healthy tissue of a patient harboring an inherited heterozygous p53 mutation, and human telomerase reverse transcriptase (hTERT) was introduced to create the immortal, diploid and nontumorigenic cell line, HME50hTERT (Supplementary  Table S1 formed tumors in mice after passage through soft agar, from which the HME50-T line was derived (Hochreiter et al., 2006) (Figure 2c ). HME50-T exhibited a CIN phenotype with chromosome numbers ranging from 74-87/cell (Supplementary Table S1 ). In addition, ChIP-PCR showed an altered chromatin profile at the chromosome 5 centromere in the tumor-derived cell line when compared to its diploid parent, with a reduction in H3K9me3 on D5Z2 relative to D5Z1 (P ¼ 0.001; Figure 2c ). Thus, disruption of the pathways regulating centromeric chromatin structure occurred concomitantly with transformation and acquisition of a CIN phenotype.
To explore the in vivo relevance of these findings, pericentromeric heterochromatin structure was analyzed in a panel of invasive ductal carcinoma (IDC) breast tumors and adjacent healthy breast tissue. Consistent with the cell line data, a more modest but significant reduction of kinetochore proximal H3K9me3 on D5Z2 was detected at centromere 5 in IDC tumors (P ¼ 0.014; Figure 2d ; Supplementary Figure S4) .
In contrast to H3K9me3, the ChIP-PCR showed a distribution of CENP-A at the chromosome 5 centromere that was conserved among all the normal and tumor-derived samples examined (Figure 1b ; Supplementary Figure S1 ; not shown).
Analysis of centromere 7 chromatin structure in normal cells, cancer cells and IDC tumors To determine whether the altered chromatin structure at the centromere of chromosome 5 extends to other chromosomes, we characterized a second centromere on chromosome 7, where two HOR alpha-satellite sequences, D7Z1 and D7Z2, map to the primary constriction (Wevrick and Willard, 1991; Finelli et al., 1996) . HOR units of both sequences were found to contain intact CENP-B box sequences (not shown). Interestingly, and consistent with a previous study (Haaf and Ward, 1994) , IF-FISH on chromosome spreads from HT1080 cells showed CENP-A localizing predominantly to D7Z1, while largely excluded from D7Z2 (Figure 3a ). D7Z1 overlapped with the CENP-A double dot signals and also spanned the inner centromere region in the majority (33/35) of chromosome 7 examples (Figure 3a) . These data suggest that factors additional to the CENP-B box influence the site of CENP-A/kinetochore formation. Confirming the IF-FISH results, ChIP-PCR showed that only D7Z1 was detectably enriched by precipitation with an antibody to CENP-A, thus identifying D7Z1 as the location of the kinetochore (Figure 3a) . This organization appeared conserved in all normal and tumor-derived samples (Supplementary Figure S1 ; not shown). The relationship between D7Z1, the flanking D7Z2 sequence and CENP-A is illustrated in Figure 3a .
ChIP-PCR with an H3K9me3 antibody showed similar enrichment for D7Z1 and D7Z2 relative to GAPDH in HUVECs (Figure 3b ). Following the pattern at the chromosome 5 centromere, H3K9me3 was reduced on the kinetochore-forming D7Z1 sequence in HT1080 cells relative to the flanking D7Z2 sequence (P ¼ 0.005) and GAPDH (Po0.05) when compared with HUVECs (Figures 3b and c) . Similar to chromosome 5, Figure 3c ). Again, the findings mirror changes in vivo, as H3K9me3 was also reduced on D7Z1 relative to D7Z2 in IDC breast tumors (P ¼ 0.001; Figure 3d ; Supplementary Figure S4 ).
JMJD2 demethylase-driven loss of pericentromeric H3K9me3 may contribute to CIN
Transcriptome analysis of a panel of 10 estrogen receptor-, progesterone receptor-, human epidermal growth factor receptor-2-negative (triple-negative) breast tumors (TNBTs) revealed robust upregulation of JMJD2A and JMJD2B histone lysine demethylases relative to laser-captured normal breast epithelium from 10 healthy volunteers (Figure 4a ; Radovich et al., submitted), while JMJD2B expression was also significantly elevated in HME50-T when compared with HME50hTERT (not shown). In comparison to normal breast, ChIP-PCR analysis of centromeres 5 and 7 in TNBTs revealed a significant loss of H3K9me3 from the kinetochore-forming sequences relative to both a ribosomal DNA arm reference and the flanking alphasatellite sequence (Figure 4b; Supplementary Figure S5 ). In the three TNBTs examined (included in the ChIP-PCR analysis), FISH with probes for centromeres 7 and 17 revealed aneuploidy and instability for both chromosomes based on deviation from the modal chromosome number (Figure 4c) .
In order to test the effect of JMJD2B overexpression on chromosome segregation, diploid HME50TR cells ( Figure 2c ) were transiently transfected with a myctagged JMJD2B expression construct. As shown in Figure 5a , cells expressing JMJD2B-myc exhibited a profound loss of nuclear H3K9me3. Significantly, the pronounced H3K9me3 foci, which colocalize with CENP-A and likely include pericentromeric H3K9me3 ( Figure 5c ) were largely abolished. No effect on the H3K9me3 level was observed in control cells transfected with an enzymatically inactive H188A JMJD2B mutant construct (Figure 5b) (Whetstine et al., 2006) . JMJD2B-transfected cells were accumulated in mitosis using nocodazole treatment, and then blocked in anaphase, permitting a direct evaluation of segregation error rates by FISH. A six-fold increase in the X chromosome missegregation rate was detected in JMJD2B-transfected cells compared with cells transfected with the JMJD2B mutant control (P ¼ 0.002; Figure 5d ).
Discussion
Tumors frequently exhibit CIN, leading to large scale genetic changes that can promote tumor progression ( Kops et al., 2005) . This study finds evidence that an altered centromere structure may contribute to the CIN phenotype. Centromere function depends on incorporation of CENP-A into nucleosomes at the kinetochore domain and the formation of flanking pericentromeric heterochromatin. Overexpression of CENP-A has been linked to CIN in colon tumors and causes chromosome mis-segregation in colon cancer cells (Tomonaga et al., 2003; Amato et al., 2009) . In model organisms, disruption of the pathways which maintain pericentromeric heterochromatin has been linked to chromosome mis-segregation and cancer (Bernard et al., 2001; Peters et al., 2001; David et al., 2003; David et al., 2006; Bourgo et al., 2009) .
Aberrant DNA methylation and histone acetylation are known to be associated with tumorigenesis and can result in epigenetic gene mis-regulation such as silencing of tumor suppressor genes (Esteller, 2008) . Successful cancer treatment strategies have been developed, which target the DNA methyltransferases or histone deacetylases involved (Rodriguez-Paredes and Esteller, 2011) . Cancer-associated changes in histone methylation patterns have also been reported at various genomic locations, including the X centromere (Esteller, 2008; Mravinac et al., 2009) . However, the association between aberrant pericentromeric histone modification and CIN in cancer cells has not been examined.
Here, we employed cytological and ChIP-PCR-based methods to compare the chromatin architecture of the centromere in normal and tumor-derived cell lines, and tissues. The analysis focused on the centromeres of chromosomes 5 and 7, each of which harbors two adjacent blocks of HOR alpha-satellite DNA with divergent sequence composition. At both centromeres, IF-FISH and ChIP-PCR analysis mapped CENP-A and the kinetochore domain to one of the two HORs. This organization was conserved in all samples examined, representing a total of 14 individuals. Significantly, the results show that CENP-A is restricted to a subset of the available HOR alpha-satellite blocks on autosomal centromeres by a mechanism that remains to be determined. In contrast to the CENP-A distribution, ChIP-PCR revealed that pericentromeric H3K9me3 extended over both HORs on chromosomes 5 and 7, although at least in the case of chromosome 5, the kinetochore flanking HOR was dispensable for centromere function. When compared to primary HUVEC samples and normal breast epithelial cells, cancer cell lines with a CIN phenotype exhibited a marked alteration of the pericentromeric H3K9me3 distribution that was consistent with a loss of kinetochore proximal heterochromatin. Furthermore, IF analysis of the chromosomally unstable fibrosarcoma-derived HT1080 cell line pointed to a more genome-wide loss of (a) JMJD2A and JMJD2B are elevated in TNBTs (n ¼ 10) compared with laser-captured normal breast epithelium (n ¼ 10). Relative expression levels (reads per kb-exon per million mapped reads) are plotted for each sample. Expression of JMJD2C and JMJ2D did not differ significantly (not shown). (b) Chromatin immunoprecipitation and PCR (ChIP-PCR) analysis of TNBTs and normal breast tissue (n ¼ 4-6/group). Enrichment is shown relative to the rDNA arm reference, which is set to 1. H3K9me3 is significantly reduced on the kinetochore-forming sequences of chromosomes 5 (D5Z2) and 7 (D7Z1) in TNBTs compared with normal breast tissue (P values A and C, respectively), but did not significantly differ on flanking D5Z1 and D7Z2 sequences (P-values B and D). The range of H3K9me3 enrichment levels on D5Z1, D5Z2, D7Z1 and D7Z2 in individual TNBT tumors and normal tissue samples is shown in Supplementary  Figure S5 . H3K9me3 loss from the kinetochore-forming sequences at centromeres 5 and 7 was also significant relative to the flanking alpha-satellite sequences when TNBTs were compared with normal breast tissues. P-values are 0.027 and 0.014, respectively. (c) FISH image of an aneuploid TNBT nucleus using centromere 7 (red; D7Z1) and 17 (green) probes. 20-22 nuclei were scored for each of three TNBTs. Modal copy number and range for chromosomes 7 and 17 in the three TNBTs is shown. CIN was measured as % nuclei exhibiting deviation from modal copy number for chromosomes 7 and 17 in three TNBTs. In comparison % deviation for chromosomes 17 and X in four uncultured stromal vascular fraction control (C) samples (n ¼ 1197 nuclei) was 1.17% (Grimes et al., 2009) .
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H3K9me3 from the vicinity of the kinetochore. The possibility of a mechanistic link between the altered pericentromeric H3K9me3 distribution and a CIN phenotype was further strengthened by examining an ex vivo breast cancer model, which comprises serially derived human breast epithelial cell lines recapitulating tumor progression and the acquisition of CIN. In comparison to its untransformed diploid parent, the tumorigenic and chromosomally unstable derivative cell line, HME50-T, exhibited a similar pattern of pericentromeric H3K9me3 alteration. A more modest but significant change in pericentromeric H3K9me3 was also seen in a comparison of invasive ductal carcinoma tumors with healthy genetically matched breast tissue. The reduced magnitude of change detected in tumors may reflect the presence of normal cells within tumor samples, and/or the observation that CIN is a feature of only approximately 45% of invasive breast tumors (Lingle et al., 2002) . Given the documented importance of pericentromeric heterochromatin for centromere function, the association found in the present study supports a model in which failure to maintain adequate kinetochore proximal heterochromatin contributes to CIN in human cancer.
As the H3K9me3 modification has a role in epigenetic gene regulation, the oncogenic consequences of JMJD2 demethylase overexpression are likely to include transcriptional effects on downstream genes (Liu et al., 2009; Pedersen and Helin, 2010; Yang et al., 2010) . However, an effect on centromere function and chromosome segregation would also be predicted but had not been tested. Our analysis of a panel of TNBTs revealed robust overexpression of JMJD2A and JMJD2B relative to normal breast epithelium from healthy donors, as well as a pattern of pericentromeric H3K9me3 alteration that mirrored the above findings. Consistent with a recent report detailing high levels of aneuploidy in TNBTs (Malorni et al., 2010) , the three TNBTs examined in this study also exhibited aneuploidy and a CIN phenotype. Endogenous JMJD2B was also overexpressed in the ex vivo breast cancer progression model (not shown) and in diploid HME50TR cells overexpression of exogenous JMJD2B largely abolished H3K9me3 staining, including the pericentromeric H3K9me3 foci, and resulted in a significant increase in the chromosome mis-segregation rate.
In light of these findings, elevated JMJD2 demethylase activity in tumors has the potential to promote CIN via pathways including pericentromeric H3K9me3 loss. However, other mechanisms must be considered. In particular, reversal of H3K36 methylation, which is also enriched at centromeric regions and may be important for centromere function (Bergmann et al., 2011) , could be involved. Furthermore, the effect of JMJD2 overexpression on downstream gene regulation means that an impact on CIN independent of pericentromeric H3K9me3 loss is also possible. Cell cycle kinetics preclude detection of an effect on centromere function Figure S6) . rapidly enough to exclude involvement of downstream gene activity. In future, centromeric targeting of a JMJD2 fusion construct, as recently reported with another histone lysine demethylase, LSD1 (Bergmann et al., 2011) , could show if altered centromeric chromatin structure in isolation is a driver of CIN. It is notable that our ChIP-PCR analysis finds a selective reduction of H3K9me3 on the kinetochoreforming sequence relative to the adjacent HOR alphasatellite DNA and other arm sequences. While the mechanism is unclear, it may be speculated that the relatively open chromatin conformation at the kinetochore (Sullivan and Karpen, 2004) and alpha-satellite transcription (Wong et al., 2007; Ting et al., 2011) favor access of the relevant histone modifiers, or that some other targeting mechanism is involved. Clearly, causes of pericentromeric H3K9me3 perturbation other than demethylase overexpression can be envisaged and warrant investigation. Potential candidates include mis-expression of the SUV39H1/2 methyltransferases whose inactivation in mice eliminates pericentromeric H3K9me3 and drives CIN, and tumorigenesis (Peters et al., 2001 ). In addition, pRb, one of the most frequently mutated genes in human cancer, as well as the chromatin remodeling complexes SWI/SNF and mSds3, are all required for faithful chromosome segregation and tumor suppression and have been implicated in the maintenance of pericentromeric heterochromatin and H3K9 methylation (David et al., 2003; Gonzalo et al., 2005; David et al., 2006; Bourgo et al., 2009; Sullivan et al., 2011) .
Considering the multitude of factors influencing chromosome segregation it would be unsurprising if cancer cells evolve many different routes to a CIN phenotype and evidence suggests this to be the case (Thompson et al., 2010) . Disruption of pericentromeric heterochromatin may represent one such pathway, either sufficient in itself or requiring additional cooperative changes. In either case, this epigenetic component to the CIN phenotype could present new therapeutic targets in the form of reversible chromatin changes. Perhaps agents such as inhibitors of JMJD2 demethylases, under current development (Rose et al., 2010; Lohse et al., 2011) , could have dual therapeutic potential, targeting both epigenetic gene mis-regulation and CIN.
Materials and methods

Cell culture
HeLa, HCC1937 and HME50-T cells were grown in DMEM/ 10% FBS, HT1080 cells in alpha-MEM/10% FBS and HUVECs in EGM2 medium (Lonza, Walkersville, MD, USA)/10% FBS. HME5cdk4 are primary breast epithelial cells expressing exogenous CDK4 to extend lifespan (Herbert et al., 2002; Ramirez et al., 2003) . HME5cdk4, HME50hTERT and HME50TR cells were grown in supplemented MCDB 171 medium (Invitrogen, Carslbad, CA, USA) (Ramirez et al., 2003) . BF lymphoblastoid cells were grown in RPMI1640 medium/15% FBS and have the designation 47,XY, del(5)(p10p13), þ r(5)(p10p13) (Schuffenhauer et al., 1996) . HeLa and HT1080 cell lines were obtained from ATCC (Manassas, VA, USA). HCC1937 were a kind gift from Dr Shay (Hammond Cancer Center, UT Southwestern, Dallas, TX, USA). Cell lines were cultured for less than 6 months at a time and verified by morphology.
Normal and tumor breast tissues Breast tumors and normal breast tissues were purchased from the IU Simon Cancer Center (IUSCC) tissue bank (Indianapolis, IN, USA) and Origene (Rockville, MD, USA). Normal breast tissues from healthy volunteers for the transcriptome analysis were obtained from Susan G. Komen for the Cure Tissue Bank at the IUSCC.
Chromatin immunoprecipitation and PCR
Chromatin was extracted from a minimum of 100 mg per tissue sample and 6 Â 10 6 cells per cell line. Nuclear isolation and chromatin digestion by micrococcal nuclease were performed as described (Yoda et al., 2004) . Chromatin fractions were incubated with anti-CENP-A (Abcam, Cambridge, MA, USA), anti-H3K9me3 (Abcam) or zero antibody (beads control; Millipore, Bedford, MA, USA). Samples were processed according to the manufacturer's protocol (Millipore). Relative quantitation of target sequences in the input chromatin, the immunoprecipitated fractions and controls was performed by real-time PCR using SYBR green chemistry and an Applied Biosystems 7500 cycler (Foster City, CA, USA). Each PCR reaction was performed in duplicate. Primers are listed in Supplementary Table S2 . For cell lines, a minimum of three replicate cultures was examined, with the exception of HCC1937, which was based on two replicates. HUVEC replicates represented three individual donors. The number of tumor and normal breast tissue samples used in ChIP-PCR are indicated in Figures 2-4 . The Student's t-test was used to measure significance of differences in ChIP-PCR in cell lines and TNBT/normal tissue comparisons. A paired t-test was used for comparison of matched IDC tumor/normal tissues. Error bars represent s.e.m.
Immunofluorescence and fluorescence in situ hybridization CENP-A (Abcam), H3K9me3 (Abcam), CENP-E or c-myc (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibodies were used in IF (see supplementary protocols). FISH probes were pG-A16 (D5Z1) (Hulsebos et al., 1988) , pZ5.1 (D5Z2) (Archidiacono et al., 1995) , D7Z1 (p7t1) (Waye et al., 1987) , D7Z2 (pMGB7) (Waye et al., 1987) , GDNF (Schindelhauer et al., 1995) or commercial CEP 17 and CEP X probes (Abbot Molecular, Des Plaines, IL, USA). DNA was counterstained with DAPI. Prior to micrococcal nuclease digestion, a fraction of TNBT nuclei harvested for ChIP were pelleted and resuspended in fixative (3:1 v/v methanol:acetic acid), and processed for FISH (Figure 4 ). Images were captured at Â 100 magnification using a Spot RTKE camera (Diagnostic Instruments, Sterling Heights, MI, USA), mounted on a Leica DN5000B microscope (Leica Microsystems, Buffalo Grove, IL, USA) and modified to increase brightness and/or contrast using Photoshop.
JMJD2B constructs, transfection and anaphase assays A myc-tagged JMJD2B expression construct was purchased from Origene. An inactivating H188A mutation (Whetstine et al., 2006) was introduced using site-directed mutagenesis (Quickchange; Stratagene, La Jolla, CA, USA). JMJD2B constructs were transfected into HME50TR cells using Lipofectamine 2000 (Invitrogen) . At approximately 48 h following transfection, cells were accumulated in mitosis using nocodazole, blocked in anaphase and processed for FISH (Sullivan and Warburton, 1999) . Transfection efficiency was estimated at B60% using a GFP reporter (not shown).
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